PT Pfizer Indonesia
28th Floor World Trade Center 3
Jl. Jend. Sudirman Kav.29-31,
Jakarta 12920, Indonesia
Telp: +62-21-8086 1400
PP-UNP-IDN-0203-FEB-2023
For healthcare professionals only
First-in-class CDK4/6 inhibitor Palbociclib in treating broad range of women with HR+, HER2- metastatic Breast Cancer
First-in-class CDK4/6 inhibitor Palbociclib in treating broad range of women with HR+, HER2- metastatic Breast Cancer
last update on: 08/26/2024